Novavax, Inc.

NasdaqGS:NVAX 株式レポート

時価総額:US$1.2b

Novavax 将来の成長

Future 基準チェック /36

Novavaxの収益は年間9.1%で減少すると予測されていますが、年間利益は年間66.6%で増加すると予想されています。EPS は年間72.4%で増加すると予想されています。

主要情報

66.6%

収益成長率

72.4%

EPS成長率

Biotechs 収益成長28.0%
収益成長率-9.1%
将来の株主資本利益率n/a
アナリストカバレッジ

Good

最終更新日13 Nov 2024

今後の成長に関する最新情報

Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Nov 15
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Recent updates

Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Nov 15
Novavax, Inc. (NASDAQ:NVAX) Just Reported, And Analysts Assigned A US$16.67 Price Target

Novavax Q3 Earnings Disappoint, But A Turnaround May Be Underway

Nov 13

Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues

Nov 01
Novavax, Inc.'s (NASDAQ:NVAX) 35% Dip In Price Shows Sentiment Is Matching Revenues

Novavax Q3 Earnings A Week Away - Time To Accept A New Reality

Oct 31

Novavax's Future Hinges On Sanofi Deal And Upcoming Milestones

Sep 01

Novavax, Inc.'s (NASDAQ:NVAX) Shares Lagging The Industry But So Is The Business

Aug 14
Novavax, Inc.'s (NASDAQ:NVAX) Shares Lagging The Industry But So Is The Business

Novavax: Staying Long Despite Coming Up Short In Q2

Aug 13

Novavax Ahead Of Q2 Earnings - Picking Apart The Sanofi Deal

Jul 26

Novavax: New Chapter, Questions Remain

Jun 20

Novavax, Inc. (NASDAQ:NVAX) Surges 206% Yet Its Low P/S Is No Reason For Excitement

May 14
Novavax, Inc. (NASDAQ:NVAX) Surges 206% Yet Its Low P/S Is No Reason For Excitement

Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

May 13
Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely

May 07

Novavax: Another Day Older And Deeper In

Mar 02

Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Mar 02
Novavax, Inc.'s (NASDAQ:NVAX) Shares Bounce 35% But Its Business Still Trails The Industry

Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Mar 01
Earnings Update: Here's Why Analysts Just Lifted Their Novavax, Inc. (NASDAQ:NVAX) Price Target To US$22.00

Novavax Q4 Earnings Preview: Settlement With Gavi Doesn't Solve Problems

Feb 23

Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

Sep 06
Investors Don't See Light At End Of Novavax, Inc.'s (NASDAQ:NVAX) Tunnel

業績と収益の成長予測

NasdaqGS:NVAX - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20267632471523883
12/31/202555879164-676
12/31/2024701-226-218236
9/30/2024885-285-112-91N/A
6/30/2024988-294-2414N/A
3/31/2024997-399-514-472N/A
12/31/2023984-545-773-714N/A
9/30/20231,050-549-727-655N/A
6/30/20231,597-587-737-654N/A
3/31/20231,359-1,155-753-653N/A
12/31/20221,982-658-509-416N/A
9/30/20221,847-1,322-728-641N/A
6/30/20221,291-1,476-814-744N/A
3/31/20221,403-1,318-489-429N/A
12/31/20211,146-1,744265323N/A
9/30/20211,204-1,075454537N/A
6/30/20211,182-950593672N/A
3/31/2021919-615575644N/A
12/31/2020476-418-97-43N/A
9/30/2020205-2734962N/A
6/30/202050-933237N/A
3/31/202018-115-110-109N/A
12/31/201919-133-138-137N/A
9/30/201916-150-160-158N/A
6/30/201921-177-162-159N/A
3/31/201929-182-171-169N/A
12/31/201834-185-186-185N/A
9/30/201839-186-184-183N/A
6/30/201839-186N/A-194N/A
3/31/201835-186N/A-166N/A
12/31/201731-184N/A-144N/A
9/30/201726-190N/A-162N/A
6/30/201721-212N/A-181N/A
3/31/201717-247N/A-230N/A
12/31/201615-280N/A-259N/A
9/30/201616-302N/A-249N/A
6/30/201619-269N/A-215N/A
3/31/201631-210N/A-165N/A
12/31/201536-157N/A-126N/A
9/30/201537-110N/A-91N/A
6/30/201539-96N/A-78N/A
3/31/201533-94N/A-77N/A
12/31/201431-83N/A-67N/A
9/30/201433-65N/A-60N/A
6/30/201429-61N/A-59N/A
3/31/201425-56N/A-55N/A
12/31/201321-52N/A-45N/A

アナリストによる今後の成長予測

収入対貯蓄率: NVAXは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 2.6% ) よりも高い成長率であると考えられます。

収益対市場: NVAX今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: NVAX今後 3 年以内に収益を上げることが予想されます。

収益対市場: NVAXの収益は今後 3 年間で減少すると予想されています (年間-9.1% )。

高い収益成長: NVAXの収益は今後 3 年間で減少すると予測されています (年間-9.1% )。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: NVAXの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘